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An in vitro model for partial-thickness cutaneous wound 
healing is described in which the influence of variables 
present in vivo, such as blood-borne factors and inflamma-
tory cells, is eliminated. Dermal sheets of porcine skin are 
maintained in culture at the air-liquid interface in serum-free 
medium, and re-epithelialization from the keratinocytes of 
the hair infundibula can be studied. 
Dermal sheets of different thicknesses harvested from var-
ious depths were first evaluated for viability and regenerative 
potential in serum-supplemented medium. Mid-dermal ex-
plants, 20/1000 inch thick, showed the greatest epithelial 
outgrowth from the appendigeal keratinocytes and the long-
est viability in vitro. Explants of this type were used in all 
subsequent experiments. 
The effects of growth factors on re-epithelialization of the 
T he m;yority of investigations on cutaneous wound healing have concentrated on dermal repair or wound bed remodeling (1-4) with little emphasis on epider-mal regeneration. In partial-thickness wounds, re-epithelialization occurs via epibolic outgrowth ofker-
atinocytes from epidermal appendages in the wound bed and from 
viable epidermis at the wound edge. Epidermal wound healing is a 
complex process involving both migration and proliferation ofker-
atinocytes under the influence of chemical attractions. These in-
clude growth factors, cytokines, and extracellular matrix proteins 
which are present in the serum or may be secreted locally by inflam-
matory cells, cells of the immune system, fibroblasts, endothelial 
cells, or keratinocytes themselves. 
Several studies have shown that the topical application of mite-
gens can accelerate wound healing in vivo (5-1 OJ. However, the 
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explants were studied in a serum-free environment. Epider-
mal growth factor, cholera toxin, bombesin, and insulin-like 
growth factor alone and in various combinations were ap-
plied to the explant surface in aqueous solutions by micropi-
pette. Outgrowth was assessed by computerized morpho-
metric analysis (RS/1 program by BBN) at days four and 
eight. Among all factors tested, cholera toxin alone and in 
combination with insulin-like growth factor produced the 
greatest epithelial outgrowth. Nevertheless, topical applica-
tions of growth factors failed to induce complete re-epithe-
lialization within the experimental time frame. In contrast, 
explants to which cultured human keratinocyte sheets were 
topically applied regenerated a confluent and regularly strati-
fied epidermis within 6 d. J Invest Dermatol 95:341-346, 
1990 
short time course (3 - 5 d) of spontaneous re-epithelialization ([11), 
unpublished observations) and the synergistic effects of endogenous 
mitogens make it difficult to define the direct effects of an applied 
factor. Recently, cultured human epithelial allografts have been 
used as wound dressings to promote re-epithelialization of nonheal-
ing partial-thickness wounds such as chronic ulcers (12 - 15). The 
relative contributions from keratinocytes of the wound edge and the 
wound bed are difficult to determine in clinical studies. Also, it is 
unclear whether the process of immunologic graft rejection has an 
additional stimulatory effect. 
We have developed an in vitro model of epidermal wound heal-
ing in which re-epithelialization of porcine mid-dermal sheets 
occurs via keratinocyte outgrowth from the infundibula of hair 
follicles. This model simulates epidermal regeneration from follicu-
lar outgrowth in a partial-thickness cutaneous wound in the absence 
of circulating factors, inflammation, or immunologic responses. 
The promotiona l effects of cultured human keratinocyte sheets and 
topical applications of growth factors such as cholera toxin (CT), 
epidermal growth factor (EGF) , insulin-like growth factor (IGF), 
and bombesin on epidermal regeneration are compared. 
MATERIALS AND METHODS 
Explant Preparation The epidermis (20/1000 inch) was first 
removed from paravertebral areas of5-month-old female Yorkshire 
pigs (Parsons, lnc.,.Hadley, MA) with a Padgett's dermatome. Der-
mal sheets of various thicknesses (10-40/1000-inch) were then 
harvested with the dermatome from discrete areas of the exposed 
dermis. In addition, dermal sheets of 20/1 000-inch thickness were 
collected by serially cropping a single area. Different levels and 
thicknesses of explants are shown in Fig 1. 
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Figure 1. The different thicknesses of dermal ex plants obtained from para-
vertebral porcine skin. The epidermis (20/1000 inch) was removed with a 
dermatome. Then, sheets of different thickness (shaded area) were removed 
with a dermatome and processed for explant culture. 
The dermal sheets were co llected in serum-free Dulbecco-Vogt 
modified Eagle medium (DM.EM) (Hazelton Biologics, Inc. , St. 
Lenexa, KS). Squares (0.5 cm2) of dermis containjng at least 12 
truncated hair follicles were placed onto dressing sponges in multi-
well Petri dishes (Fig 2a) and maintained at the air-liquid interface 
in 95% humidity at 37°C. Initially, explants were maintained in 
DM.EM with 10% FCS (Sigma Chemical Co., St. Louis, MO) to 
determine the optimal level and thickness of dermis suitable for 
explants. T he med ium, supplemented with penicill in (1 ,000 
U jml) , and streptomycin (1 mgjml), was changed every 3-4 d. 
Hydrocortisone (0 .4 ,ugfml, Calbioc hem, La Jolla, CA) was added 
to the medium in a concentration low enou gh not to inhibit ce ll 
proliferation but high enough to prevent glycogen deposition and 
necrosis of rema ining appendi geal keratinocytes and to inhibit col-
lagenase activity (1 6]. The C02 concentration was maintained at 
10% instead of the usual 5%, because a more acidic pH reduces 
collagenase secretion of fibroblasts in vitro [ 17]. 
All growth factor and keratinocyte experiments were performed 
in serum-free DMEM. Co,ntrol explants were kept in serum-free 
DM.EM and treated with topical applications of di luent for mito-
gens alone. 
Histologic Analysis Hematoxylin and eosin-stained sections of 
forma lin-fi xed, paraffin-embedded explants were examined for tis-
sue viability. Portions of selected explants were fixed in 2.5% glu-
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taraldehyde, embedded in plastic, and eva luated ultras tructurally fo 
evidence of tissue degeneration (autolysis or collagen breakdovvn), 
Mitogen Preparation Growth factors were diluted in steril~ 
water with either 1 o/o bovine serum albumin (bombesin , EGF, IGF) 
or serum -free medium (CT), and applied topically to the surface 0 ' 
explants by micropipette (maximum volume 100 ,ul). Dose-_ 
response curves through th e followin g concentrations were oh.. 
rained: bombesin (6 - 600 nM, Sigma C hemical Co., St. Loui 
MO); cholera toxin (0.01 - 1 nM, Schwarz/Mann Biotech, Ca01~ 
bridge, MA); human recombinant EGF (0.2-20 nM, generous gift 
of Ch iron Corp., Emeryvil le, CA); and human recombinant IGI\ 
(1 - 100 nM, Bachem, Torrance, CA). T he lowest maximally effec, 
tive concentration for each growth factor was used in all subsequent 
experi ments. For the fo llowing combinations of bombesin + CT, 
bombesin + IGF, and CT + IGF, the lowest maximally effectiv~ 
concentration of each mitogen was used. Each concentration o 
growth fac tor was tested in a total of 12 explants. 
Cultured Keratinocyte Sheets Sheets were generated fro ll\ 
fres h and froze n newborn foreskin keratinocytes and grown on a 
lethally irradiated 3T3 fibroblast feeder layer (1 8, 19]. Cell sbee 
were detached w ith 0.25% Dispase solution and transferred to the 
exp lant surface on silastic sheeting (Dow Corning, Midland, MI), 
which was removed after placement of the cultured xenografts on 
the exp lant surface. Keratinocyte sheets from second, third , and 
fourth passages were placed onto the explant surface at day 0 and lefi 
in place until harvesting. Control explants were covered witn 
Figure 2. (a) Islands of regenerated epithelium can be distinguished frot. 
th e dermis in a dermal explant treated with 1 nM CT (magnification X2.:\ 
(b) T he surface of a dermal explant in serum-free medium at day 8. In 
serum-free environment, ke ratinocytc islands do not coalesce, even wb 
their edges arc closely approaching (magnification X 50, arrow). D, derm· 
E, regenerated epithelium. 
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Kal tostat absorbent hemostatic wound dressing (BritCair Limited, 
Aldershot, UK (20]) . 
Morphometric Analysis At least 10 hair follicles per explant 
were photographed en face under the microscope (Fig 2b). Epithe-
lial outgrowth was determined by computerized morphometric 
analysis from photomicrographs of the explant surface (total 
magnification X 50). Relative outgrowth was determined as the 
ratio of the perifollicular area covered by epithelium to the cross-
sectional area of the hair follicle using the RS/1 program by BBN 
(mean, standard variation, SEM). 
RESULTS 
Exflant Cultivation The optimal thickness and depth of der-
ma sheets to be used as explants were determined in DMEM sup-
plemented with 10% FCS. Dermal sheets of different thicknesses 
(10/1000, 20/1000, 30/1000, and 40/1000 inch) were first har-
vested from discrete areas (Fig 1). The greatest degree of epithelial 
outgrowth and longest viability in vitro was observed with 
20/1 000-inch-thick explants. Among 20/1000-inch explants from 
different dermal depths (superficial dermis to the subcutaneous adi-
pose tissue), the great~st regenerative ~otential ~as ass?ciated wit_h 
mid-dermal sheets (F1g 3a) that contamed the mfund1bula of ha1r 
follicles . The keratinocytes of the infundibula gave rise to the re-
generating epidermis. After a 3-d incubation in serum-supple-
mented DMEM, centrifugal migration of keratinocytes was seen 
around all follicles (Fig 3b). By day 6, bridging of adjacent perifolli-
cular epithelial collars was observed. After 12 d, the regenerating 
epithelium was about 70% confluent. The regenerated epidermis 
appeared slightly thinner and less well organized than normal por-
cine skin (Fig 3c). The basal cell layer was well organized, but the 
stratum corneum was either absent or poorly developed. In serum-
free DMEM, epithelial outgrowth slowed markedly after 3-4 d. 
After 12 d narrow perifollicular epithelial collars had formed, but 
bridging between adjacent collars was not observed. The total ab-
sence of serum did not affect the viability or histologic appearance of 
explants. There were no signs of collagen breakdown or necrosis in 
the dermis by either light or electron microscopic examination. The 
nuclei appeared healthy and the cytoplasm of keratinocytes was 
non-vacuolated. 
Treatment with Cultured Keratinocytes Application of cul-
tured keratinocyte sheets to the explant surface in serum-free me-
dium greatly increased epithelial outgrowth. Re-epithelialization 
of the explant surface by keratinocytes clearly originating from 
follicular infundibula was observed beneath the intact xenograft on 
histological examination at day 4 (Fig 4a). At 6 d, the remains of the 
degenerating overlying xenograft were still identifiable, but the 
explant had regenerated a confluent well-differentiated epidermis 
(Fig 4b). The newly formed epidermis was fully stratified and had a 
thin stratum corneum. Even deep dermal explants, which on initial 
screening in serum-supplemented medium displayed limited poten-
tial for re-epithelialization, regenerated a confluent epidermis 
which was thicker than normal porcine epidermis within 10 d fol-
lowing topical application of cultured keratinocyte sheets. Serial 
subculture of human keratinocytes prior to topical application to 
explants did not diminish their epithelial growth-promoting activ-
ity. 
Treatment with Growth Factors In dose-response determina-
tions, the lowest concentration producing maximum outgrowth in 
asingle application was 1 nM for CT, 60 nM for bombesin, 10 nM 
for IGF, and 2 nM for EGF. Reapplication of mitogen further in-
creased outgrowth in some cases. A second application ofbombesin, 
EGF, or IGF increased re-epithelialization significantly over that 
produced by a single dose (Fig 5). However, reapplication of CT at a 
aose of 1 nM or greater had no additional effect. Among mitogen 
combinations, CT + IGF and CT + bombesin increased epithelial 
outgrowth only slightly over that observed with CT alone (Fig 6). 
However, none of the mitogen combinations produced complete 
re-epithelialization of the explants (Fig 7) . 
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Figure 3. (a) Mid-dermal explant, 20/1000-inch thick, after harvest (mag-
nification X 75). (b) At 3 din culture, keratmocytes have migrated outward 
from the root sheath of the follicular infundibulum (magnification X 150, 
arrows at migrating edge). (c) At 12 d, the regenerating epithelium at the 
edge of the perifollicular collar appears attenuated (magnification X 150, 
arrows). (d) Regenerated island in a CT-trcated explant shows marked mi-
totic activity (magnification X 75). H, hair. 
On histologic examination, regenerated epidermis in explants 
treated with CT, alone or in combination with other mitogens, 
appeared hyperplastic and was 10 cell layers thick. Compared to 
explants grown in FCS-supplemented DMEM (Fig 3c), the basal 
layer of the regenerated epidermis had an irregular contour and 
contained multiple mitotic figures (Fig 3d). Bombesin- and IGF-
treated explants showed a slightly less hypertrophic epithelium (6-
8 cell layers thick) with a lower mitotic index. 
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Figure 4. (a) 4 days after topical app lication of second-passage cultured 
keratinocyte sheets (X 70). Note the outgrowth of keratmocytes from the 
hair follicl e and the degenerating cell sheet on top of rhe regenerating 
epithelium. (b) Mid-dermal explant, 7 d (magnification X 150). C? cell 
debris from degenerating cultured xenograft, D, derm1s; E, ep1derm1s; H, 
hair foll icle; S, stratum corneum. 
DISCUSSION 
We have found that mid-dermal sheets measuring 20/1000 inch in 
thickness constitute the optimal explant type for use in investigating 
epidermal wound healing of those large partial-thickness cutaneous 
wounds (e. g., donor sites for split-thickness skin grafts in_ b~rn pa-
tients), in which the wound edge is remote and re-ep1theltahzatwn 
occurs largely fro m epidermal aprendages in tl_1 e wound bed. As 
previously shown by Lenoir et al[21 ], the keratmocytes of dermal 
explants will regenerate an epidermis via epibolic outgrowth from 
hai r follicles. In contrast to the situation in vivo, however, wound 
healing can be observed in an environment devoid of circulating 
growth factors and inflammatory products. 
Previously described cutaneous organ culture systems have em-
ployed ex plants comprised predominantly (up to 80%) of epidermis 
in w hich keratinocyte outgrowth from the explant periphery is 
observed {22- 30) , simulating epithelial regeneration from the 
wound edge. The biologic responsiveness of interfollicular kerati-
nocytes may be different from keratinocytes of hair follicles. In our 
explant model, the regenerative potential of skin appendages can be 
studied in isolation. 
Interfollicular epithelial bridging was seen almost exclusively in 
serum-maintained explants ,. Migration ofkeratinocytes is facilitated 
by serum proteins such a/ thrombospondin, fibronectin, epibolin 
and co-epibolin [31 ,32}. Perifollicular epithelial bridging was seen 
in some explanrs treated with EGF, but EGF is known to stimulate 
migration ofkeratinocytes [33). Human recombinant EGF failed to 
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Figure 5. Keratinocyte outgrowth shown as ratio of the area of regenera 
epithelium to the area of the hair follicle in non-confluent epidermal regen\ 
eration. Effect of one versus two app lications at day 8. Application of mi~ 
gen at day 0 (clear) and day 4 (hatched). Numbers in bars denote stan~ 
deviation. Error bars, SEM. Bomb, bornbesin; CT, cholera toxin; EGF, ep~ 
derm~l growth factor; DME, Dulbecco-Vogr modified Eagle's medilllll( 
JGF, msuhn-hke growth factor: 
though EGF has been shown to be essential for maximal expansi 
of cultured human keratinocytes [33 ,34] and has recently been d~ 
ons_trated to enhance healing of split-thickness graft donor sites · 
patients w hen topically applied [5], some investigators have b 
un~uccessful in promoting wound healing using EGF in humans 1 

























Figure 6. Proportional outgrowth at day 8 after two applications (dO, d4) •I 
mitogens. N umbers in bar, SD. Error bars, SEM. Bomb, B, bombesin. 
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Figure 7. Re-epithelialization of mid-dermal explants. e, cultured keratin-
ocyte xenografts; +, 10% FCS supplemented DMEM, medium change 
every 3 d; x, CT / IGF, applied at day 0, 4, and 8 with the medium change. 
nocytes to human recombinant EGF (also see [38]) suggests a spe-
cies-specific difference in the EGF-receptor. 
Bombesin, known as a potent mitogen for 3T3 fibroblasts [39]. 
was found to induce epidermal regeneration. In vivo, it is difficult to 
assess the direct growth-promoting effect of bombesin because the 
administration of this peptide stimulates the secretion of other bio-
logically active peptides w hich might act as proximal effectors of 
bom besin and mask its direct effects. In this serum-free explant 
model, the source of proximal effectors ofbombesin was limited to 
dermal, vascular or epidermal appendigeal cells from the explant. 
Al though re-epithelialization may have been promoted directly by 
bombesin, products secreted by bombesin-stimulated fibrobl asts 
may be the principal promoters. 
C h olera toxin, a potent cAMP promoter and highly effective 
mitogen for human keratinocytes in culture [ 40,41], stimulates epi-
dermal growth in vivo after intradermal injection in mice, rats and 
hamste rs [42] . In our model, CT proved to be a potent local pro-
moter of epidermal regeneration. It was not, however, as effective as 
cultured keratinocyte sheets. Our findin g that IGF alone did not 
significantly promote epithelial outgrowth but proved to be syner-
gistic in combination with other growth factors is similar to that of 
other investigators [43] . 
Re-epithelialization of explants treated with cultured human 
lreratinocyte sheets occurred at least three times faster than serum-
induced regeneration. An immunohistochemical labeling of there-
generated epidermis in explants after treatment w ith cultured 
human keratinocyte sheets was considered, but no anti-keratinocyte 
nor anti-basement membrane antibody from commercial or private 
sources that was (human vs pig) species-specific was found. Because 
the grafts were of foreskin origin, a human Y chromosome analysis 
could be done, as has been done clinically to show that cultured 
allografts do not survive on treated ulcers [13] . H owever, it seemed 
clear from microscopic examination that the human grafts remain 
only as keratinaceous debris over the explant surface after 6 d. 
These results support clinical observations that cultured human 
keratinocyte grafts promote wound healing. Healing of chronic 
ulcers refractory to conventional therapies is markedly enhanced 
using cultured allografts [13 ,15]. The cultured allografts do not 
remain permanently on the wound bed [12] , and their mechanism of 
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action has been attributed to stimulation of endogenous keratino-
cytes via secretion of cytokines by inflammatory cell s or stimulation 
of the immune system by the presence offoreign tissue [44]. Inflam-
matory and immune reactions are eliminated in the described ex-
plant model, indicating that enhancement of re-epithelialization 
may be attributed solely to products secreted by the cultured kerat'i-
nocytes. C ul tured human keratinocytes have been shown to pro-
duce basic fib rob last growth factor (45]. transforming growth fac-
tor-a (46,47], and many cytokines [48-51]. They also secrete 
fib ronectin , laminin, and thrombospondin, extracellular matrix 
proteins, w hich promote epithelial cell attachment and spreading 
[5 2 -58]. During the 3-week rejection phase, the secretion of mtto-
gens and extracellular matrix proteins stimulate the patient's own 
keratinocyte to heal the wound. Human dermal explants are pres-
ently being tested in this model to further elucidate species differ-
ences in responsiveness. 
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